not tagged
not tagged
['cardio']
the 2022 , , and guidelines recommend sglt2 inhibitors for nearly all patients in cardiovascular practice. read more: 
Providing #pharmacy news, clinical insights, & CE to help pharmacists deliver drug expertise & accessible patient care. Tweet us your questions & feedback!